They anticipate the company to incur a final loss in 2021, before generating positive profits of CA$1.1b in 2022. WOW!!!
"Expectations from some of the Canadian Pharmaceuticals analysts is that THC Biomed Intl is on the verge of breakeven. They anticipate the company to incur a final loss in 2021, before generating positive profits of CA$1.1b in 2022. Therefore, the company is expected to breakeven just over a year from now. What rate will the company have to grow year-on-year in order to breakeven on this date? Using a line of best fit, we calculated an average annual growth rate of 166%, which is rather optimistic! Should the business grow at a slower rate, it will become profitable at a later date than expected."
Market Data 
Markets 
AI
